Editorial: Leveraging multi-omics approaches to understand and manage gastrointestinal and hepatic diseases

Editorial: Leveraging multi-omics approaches to understand and manage gastrointestinal and hepatic diseases

Saved in:

Bibliographic Details
Main Authors:	Isis Trujillo-Gonzalez, Paul G. Thomes, Isin Tuna Sakallioglu, Kusum K. Kharbanda
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-12-01
Series:	Frontiers in Pharmacology
Subjects:	metabolic dysfunction-associated steatotic liver disease traditional Chinese medicine cholangitis gut micriobiome inflammation
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1529088/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Advances in Alcoholic Liver Disease
by: Natalia Osna, et al.
Published: (2012-01-01)

Non-alcoholic fatty liver disease and the gut microbiota in adolescents: is there a relationship?
by: Doaa El Amrousy, et al.
Published: (2024-11-01)

Ethanol Disrupts the Protective Crosstalk Between Macrophages and HBV-Infected Hepatocytes
by: Murali Ganesan, et al.
Published: (2025-01-01)

Challenges in Diagnosing Intrahepatic Cholangiolithiasis in a 39-Year-Old Patient
by: A. K. Guseva, et al.
Published: (2024-12-01)

Rare renal proximal tubular dysfunctions in primary biliary cholangitis
by: Xiaoxiao Shi, et al.
Published: (2024-12-01)

Gut Microbiota at the Crossroad of Hepatic Oxidative Stress and MASLD
by: Fabrizio Termite, et al.
Published: (2025-01-01)

Steatotic Liver Disease: New Nomenclature and Its Localization in the Russian Federation
by: K. L. Raikhelson, et al.
Published: (2024-05-01)

Genetically predicted immune cells mediate the association between gut microbiota and autoimmune liver diseases
by: Jikang Zhang, et al.
Published: (2024-12-01)

From gut to liver: Exploring the crosstalk between gut-liver axis and oxidative stress in metabolic dysfunction-associated steatotic liver disease
by: Mi Zhou, et al.
Published: (2025-01-01)

Betaine Treatment Attenuates Chronic Ethanol-Induced Hepatic Steatosis and Alterations to the Mitochondrial Respiratory Chain Proteome
by: Kusum K. Kharbanda, et al.
Published: (2012-01-01)

Editorial: Multi-omics strategy toward identifying and managing hereditary and metabolic liver diseases
by: Mingjie Wang, et al.
Published: (2024-11-01)

Impact of liver graft steatosis on long-term post-transplant hepatic steatosis and fibrosis via magnetic resonance quantification
by: Lung-Yi Mak, et al.
Published: (2025-01-01)

Role of waist circumference, body mass index and high-sensitivity C-reactive protein in pediatric steatotic liver disease: A cross-sectional study
by: Qiaoling Wu, et al.
Published: (2025-01-01)

Predictors of Hepatic Fibrosis in Type 2 Diabetes Patients with Metabolic-Dysfunction-Associated Steatotic Liver Disease
by: Joana D’Arc Matos França de Abreu, et al.
Published: (2024-11-01)

Bidirectional Mendelian randomization links gut microbiota to primary biliary cholangitis
by: Zhijia Zhou, et al.
Published: (2024-11-01)

Augmenter of Liver Regeneration Crotonylation Assists in Mitochondria-ER Contact to Alleviate Hepatic SteatosisSummary
by: Xiao-lin Wang, et al.
Published: (2025-01-01)

Exploring the epidemiology and awareness of metabolic dysfunction-associated steatotic liver disease (MASLD) among health sciences students in an academic health care institute in India
by: Umasankari S., et al.
Published: (2024-12-01)

Body habitus vs. hepatic steatosis: Understanding the drivers of non-diagnostic shear wave elastography
by: Sai Dhanush Reddy Jeggari, et al.
Published: (2024-12-01)

Consistency analysis of two US techniques for evaluating hepatic steatosis in patients with metabolic dysfunction-associated steatotic liver disease
by: Fei Chen, et al.
Published: (2025-01-01)

Prediction of hepatic fibrosis using the aspartate transaminase-to-platelet ratio index in children and adolescents with metabolic dysfunction-associated steatotic liver disease
by: Hye Young Jin, et al.
Published: (2024-11-01)

Phenotypes of primary sclerosing cholangitis in children
by: M.B. Dyba, et al.
Published: (2024-12-01)

Low-dose valine attenuates diet-induced metabolic dysfunction-associated steatotic liver disease (MASLD) in mice by enhancing leptin sensitivity and modulating the gut microbiome
by: Felicianna, et al.
Published: (2024-12-01)

The Predictive Role of miRNAs in Hepatitis B Vaccine Response of Metabolic Dysfunction-Associated Steatotic Liver Disease Patients
by: Gamze Guney Eskiler, et al.
Published: (2024-11-01)

Sarcopenia and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review
by: Ludovico Abenavoli, et al.
Published: (2024-09-01)

Effect of a Ketogenic Diet on Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD) Progression: A Randomized Controlled Trial
by: Sakkarin Chirapongsathorn, et al.
Published: (2025-01-01)

Predictors of Significant Fibrosis Among People Living with HIV with Metabolic Dysfunction- Associated Steatotic Liver Disease
by: Thaninee Prasoppokakorn, et al.
Published: (2024-12-01)

Differential prevalence and prognostic value of metabolic syndrome components among patients with MASLD
by: Jesse Pustjens, et al.
Published: (2024-12-01)

Strengthening oral care
by: Kusum Pradhan
Published: (2013-01-01)

Difficult case of endoscopic ultrasonography-guided choledochogastrostomy salvaged using a stiff guidewire
by: Takio Narikawa, et al.
Published: (2025-01-01)

On Double Summability of Double Conjugate Fourier Series
by: H. K. Nigam, et al.
Published: (2012-01-01)

Diagnostic performance of FibroTouch® in assessing hepatic steatosis and fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: An Asian experience
by: Thanikan Sukaram, et al.
Published: (2025-01-01)

Cytoskeleton Remodeling-Related Proteins Represent a Specific Salivary Signature in PSC Patients
by: Elisa Ceccherini, et al.
Published: (2024-12-01)

Correlation between family function and self-management abilities in patients with metabolic dysfunction-associated steatotic liver disease
by: Yueying Zhu, et al.
Published: (2025-01-01)

Combi-Elastography versus Transient Elastography for Assessing the Histological Severity of Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Yun Kyu Lee, et al.
Published: (2024-11-01)

Impact of hepatic steatosis on liver stiffness measurement by vibration-controlled transient elastography and its diagnostic performance for identifying liver fibrosis in patients with chronic hepatitis B
by: Zhiyuan Chen, et al.
Published: (2024-11-01)

The role of prenatal choline and its impact on neurodevelopmental disorders
by: María F. Mujica-Coopman, et al.
Published: (2024-11-01)

Meta-analysis and systematic review of liver transplantation as an ultimate treatment option for secondary sclerosing cholangitis
by: Eyad Gadour, et al.
Published: (2021-11-01)

Percutaneous transhepatic biliary intervention for the management of recurrent cholangitis secondary to intrahepatic biliary stones after hepaticojejunostomy
by: Dr Kevin Oreo, et al.
Published: (2025-02-01)

Interplay of Oxidative Stress, Gut Microbiota, and Nicotine in Metabolic-Associated Steatotic Liver Disease (MASLD)
by: Irene Mignini, et al.
Published: (2024-12-01)

Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Patients—The Relationship with Platelets Indicators
by: Danusia Onișor, et al.
Published: (2024-12-01)